NFRP Outreach and Invitation for Response
The CDMRP Neurofibromatosis Research Program is requesting feedback on a potential research-based Other Transaction Agreement to run multi-site Phase I/II clinical trials for treatments targeting NF1, NF2, and schwannomatosis. The concept envisions one operations center and at least five clinical trial sites, cost sharing, possible industry partnership, milestone-based payments, and negotiated…
Source
Keywords
Supporting Links
Documents
Similar Opportunities
-
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
-
Investigator-Initiated R01: Fully Remote mHealth Clinical Trials of Complementary and Integrative Interventions
Department of Health and Human Services ▸ National Institutes of Health
-
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Department of Health and Human Services ▸ National Institutes of Health
-
DoW Vision, Clinical Trial Award
Dept. of the Army -- USAMRAA
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers